Arglaes Powder,5.00 - BX (5 EA)

Ideal for wounds that are difficult to dress; Manages bacterialburden1; Continuous antimicrobial protection1; Extended wear time1; Non-staining \n Powder can convert any other dressing to an antimicrobial (Arglaes Powder)\n Indications: pressure ulcers, diabetic foot ulcers2, partial and full-thickness wounds, leg ulcers, negative pressure wound therapy (Arglaes Powder only)9, grafted wounds (Arglaes Powder only), donor sites, lacerations and abrasions, and first- and second-degree burns. \n Contraindications: third-degreeburns, patients with a known sensitivity to silver and as a surgical implant; do not use topical antibiotics in conjunction with Arglaes. \n Arglaes� Film may be left in place for up to 7 days; Arglaes Island and Arglaes Powder may be left in place for up to 5 days; Dressing change frequency will depend upon the amount of drainage1. Internal report on file. 2. LaJoie J. Improving diabetic foot ulcer outcomes with hyperbaricoxygen and ionic silver powder. Presented at SAWC. San Diego, CA. 2005. 3. Rogers RS, Patel M, Alvarez OM. Effect of a silver ion containing wound dressing on the bacterial burden of chronic venous ulcers. Presented at SAWC. Dallas, TX. 2000. 4. Sparks-Evans K. Charcot-Marie-Tooth Foot Deformities, Osteomyelitis with Open Wounds on a Child. Presented at Clinical Symposium on Advances in Skin and Wound Care. Phoenix, AZ. 2004. 5. Strilko BL, Barna A. The versatile use of a silver alginate powder in the treatment of a variety of wounds. Presented at WOCN. Salt Lake City, Utah. 2007. 6. Brooks KL, Dauenhauer SA, Evans JT. Decreased incidence of central line-related blood stream infections associated with use of silver impregnated dressings at central venous catheter sites. Presented at Decennial International Conference on Nosocomial and Healthcare Associated Infections. Atlanta, GA. 2000. 7. Pittman J, Tape J, Tanner D, Peliccia J. Comparative study of the use of antimicrobial barrier film dressing in post-operative care. Presented at WOCN. Las Vegas, NV. 2005. 8. Gonzalez VR, Segal CG, Tillman C, Houston S, Pruitt V. Changing clinical practice to reduce sternal surgical site infections (S-SSI) in open bypass surgery. Presented at Association for Professionals in Infection Control and Epidemiology, Inc. Seattle, WA. 2001.9. Curran M, Paz-Altschul OJ. The use of silver antimicrobial powder with negative pressure wound therapy. Presented at Clinical Symposium on Advances in Skin and Wound Care. Dallas, TX. 2002. 10. Independent study preformed by Wickham Laboratories Limited, Hampshire, England.

Write a review

Your Name:


Your Review: Note: HTML is not translated!

Rating: Bad            Good

Enter the code in the box below: